Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Acquired hemophilia A requiring plasma exchange and mechanical ventilation].
Takahashi W, Ichikawa M, Furuichi S, Nagasawa F, Iso H, Arai H, Tsurumi S, Handa T, Tadokoro J, Nakamura Y, Nakamura Y, Sasaki K, Mitani K. Takahashi W, et al. Among authors: tsurumi s. Rinsho Ketsueki. 2019;60(3):191-196. doi: 10.11406/rinketsu.60.191. Rinsho Ketsueki. 2019. PMID: 31068514 Japanese.
[Neutrophil alkaline phosphatase score].
Furusawa S, Tsurumi S. Furusawa S, et al. Among authors: tsurumi s. Nihon Rinsho. 1999 Sep;57 Suppl:809-12. Nihon Rinsho. 1999. PMID: 10543243 Review. Japanese. No abstract available.
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
Saito K, Nakamura Y, Aoyagi M, Waga K, Yamamoto K, Aoyagi A, Inoue F, Nakamura Y, Arai Y, Tadokoro J, Handa T, Tsurumi S, Arai H, Kawagoe Y, Gunnji H, Kitsukawa Y, Takahashi W, Furusawa S. Saito K, et al. Among authors: tsurumi s. Int J Hematol. 2000 Apr;71(3):238-44. Int J Hematol. 2000. PMID: 10846828
PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma.
Nakamura F, Arai H, Tokita K, Furuichi S, Sugita-Nagasawa F, Takahashi W, Handa T, Iso H, Tadokoro J, Tsurumi S, Nakamura Y, Nakamura Y, Sasaki K, Seo S, Ichikawa M, Mitani K. Nakamura F, et al. Among authors: tsurumi s. Leuk Lymphoma. 2021 Jan;62(1):239-242. doi: 10.1080/10428194.2020.1817442. Epub 2020 Sep 11. Leuk Lymphoma. 2021. PMID: 32914680 No abstract available.
56 results